Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionHCV non-structural protein 5B inhibitor
Molecular Target HCV NS5B polymerase
Mechanism of ActionHCV non-structural protein 5B inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat hepatitis C virus (HCV) infections
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today